CUE
Price
$0.78
Change
-$0.02 (-2.50%)
Updated
Aug 29 closing price
Capitalization
59.96M
66 days until earnings call
OCS
Price
$16.13
Change
-$0.22 (-1.35%)
Updated
Aug 29 closing price
Capitalization
844.18M
Interact to see
Advertisement

CUE vs OCS

Header iconCUE vs OCS Comparison
Open Charts CUE vs OCSBanner chart's image
Cue Biopharma
Price$0.78
Change-$0.02 (-2.50%)
Volume$82.04K
Capitalization59.96M
Oculis Holding AG
Price$16.13
Change-$0.22 (-1.35%)
Volume$10.42K
Capitalization844.18M
CUE vs OCS Comparison Chart in %
Loading...
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CUE vs. OCS commentary
Sep 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Hold and OCS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 01, 2025
Stock price -- (CUE: $0.78 vs. OCS: $16.13)
Brand notoriety: CUE and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 25% vs. OCS: 83%
Market capitalization -- CUE: $59.96M vs. OCS: $844.18M
CUE [@Biotechnology] is valued at $59.96M. OCS’s [@Biotechnology] market capitalization is $844.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 0 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 0 green, 5 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, CUE is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 3 TA indicator(s) are bullish while OCS’s TA Score has 4 bullish TA indicator(s).

  • CUE’s TA Score: 3 bullish, 4 bearish.
  • OCS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OCS is a better buy in the short-term than CUE.

Price Growth

CUE (@Biotechnology) experienced а -5.54% price change this week, while OCS (@Biotechnology) price change was -9.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

CUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($844M) has a higher market cap than CUE($60M). OCS YTD gains are higher at: -5.118 vs. CUE (-28.422). CUE has higher annual earnings (EBITDA): -36.07M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. CUE (27.5M). OCS has less debt than CUE: OCS (1.1M) vs CUE (7.63M). CUE has higher revenues than OCS: CUE (8.29M) vs OCS (0).
CUEOCSCUE / OCS
Capitalization60M844M7%
EBITDA-36.07M-101.78M35%
Gain YTD-28.422-5.118555%
P/E RatioN/A63.08-
Revenue8.29M0-
Total Cash27.5M182M15%
Total Debt7.63M1.1M692%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CUEOCS
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
48%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
40%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
49%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
64%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
45%
Aroon
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 4 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWEAX9.070.02
+0.22%
American Century Equity Income A
QFVIX27.32-0.01
-0.04%
Pear Tree Polaris Foreign Value Instl
HSCYX29.87-0.21
-0.70%
Hartford Small Company Y
SVXFX69.53-0.60
-0.86%
Smead International Value I1
CLTAX16.51-0.17
-1.02%
Catalyst/Lyons Tactical Allocation A

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-1.35%
CUE - OCS
36%
Loosely correlated
-2.66%
SNSE - OCS
32%
Poorly correlated
N/A
CGEN - OCS
31%
Poorly correlated
+0.71%
PRAX - OCS
29%
Poorly correlated
-0.98%
GRI - OCS
28%
Poorly correlated
N/A
More